Cardioprotective Potential of Maharishi Amrit Kalash: A Scoping Review

A scoping review document summarizing 13 experimental and clinical studies on the Ayurvedic formulation Maharishi Amrit Kalash (MAK) and its cardiovascular benefits. The review, authored by Radha Singh and published on figshare in 2026, followed PRISMA-ScR guidelines and analyzed evidence from multiple databases. It reports findings on antioxidant mechanisms, anti-atherogenic effects, and clinical outcomes like angina reduction.

Use Cases

• Conducting a meta-analysis on antioxidant effects based on reported in vitro outcomes like LDL oxidation inhibition.
• Identifying research gaps for clinical trials based on the review's discussion of methodological limitations.
• Studying the mechanisms of Ayurvedic formulations based on the summarized anti-atherogenic and platelet aggregation modulation findings.
• Designing follow-up preclinical studies based on the reported in vivo results, such as reduced plaque formation.

Strengths

• Follows a structured methodology (PRISMA-ScR guidelines) for evidence synthesis.
• Aggregates findings from 13 distinct studies across multiple databases, including PubMed and clinical trial registries.
• Explicitly identifies evidence gaps and methodological limitations to guide future research.

Limitations

• The dataset is a 28.9 KB document; the underlying primary data from the 13 reviewed studies is not included.
• Column-level documentation is absent; field semantics must be inferred from the review text after download.
• Row count is unknown, which may limit suitability assessment for quantitative analysis.

Provenance

Source

figshare

Collection Method

Scoping review conducted via literature search across PubMed, AYUSH Research Portal, Google Scholar, DHARA, EBSCO, and CTRI.

Freshness

Last updated 2026-05-14 05:23:42; freshness should be verified.